Outcome by “Minimal Residual Disease response” after the first consolidation course in CBF AML cumulative incidence of relapse (CIR): At 36 months CIR was estimated at 22% (95% CI, 16-32) in patients who achieved a 3 log MRD reduction vs 54% (95% CI, 39-69) in those who did not. See figure 5A in the article by Jourdan et al that begins on page 2213.